Nefiracetam CAS No.:77191-36-7 99.0% purity min. for nootropic

1.Product introduction

 Nefiracetam belongs to the piracetam family, a class of drugs known for their cognitive-enhancing properties. Nefiracetam was first synthesized in the early 1980s and quickly attracted attention due to its unique mechanism of action and potential therapeutic applications. This racemic compound is thought to affect neurotransmitters and receptors in the brain, ultimately promoting improved cognitive abilities. Nefiracetam primarily affects brain levels of acetylcholine, a key neurotransmitter responsible for memory, learning, and cognitive function. By modulating acetylcholine receptors, nefiracetam promotes increased communication between neurons, thereby enhancing synaptic plasticity and improving memory retention. In addition, nefiracetam interacts with gamma-aminobutyric acid (GABA) receptors to help balance the neurotransmitter milieu. By positively affecting excitatory and inhibitory neurotransmitters, nefiracetam helps maintain optimal brain function, thereby improving focus, attention, and overall cognitive performance.

2.Feature

 (1) High purity:Nefiracetam can obtain high-purity products through natural extraction and refining production processes. High purity means better bioavailability and fewer adverse reactions.

 (2) Safety: High safety, few adverse reactions, no obvious adverse reactions even with long-term use. But you need to pay attention to dosage and allergies.

 (3) Stability: Nefiracetam has good stability and can maintain its activity and effect under different environments and storage conditions.

 (4) Easy to absorb: Nefiracetam can be quickly absorbed by the human body and distributed to different tissues and organs.

3.Applications

 Nefiracetam is a hydrophobic derivative of piracetam, which is generally considered to be a substance responsible for the discovery of calcium channels in the body and the indirect transfer of excitatory signaling substances as a partial agonist of calcium ion channels.  Glycine binding site of NDMA receptor. Through its effect on the cerebral cortex, nefiracetam can enhance cognitive abilities and prevent learning and memory impairment. It does not possess muscarinic receptor agonist or antagonist properties, nor does it inhibit acetylcholinease activity. Therefore, its anti-amnestic and memory-enhancing effects are achieved by improving the release of acetylcholine in the cerebral cortex.